Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: Cause or results?

(2014) Hidenori Toyoda et al.   HEPATOLOGY

P1032 LOW ACCURACY OF NON-INVASIVE TESTS FOR ASSESSING RESIDUAL CIRRHOSIS IN HEPATITIS C PATIENTS WITH A SUSTAINED VIROLOGICAL RESPONSE

(2014) E. Degasperi et al.   JOURNAL OF HEPATOLOGY

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis

(2013) Soo Aleman et al.   CLINICAL INFECTIOUS DISEASES

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection

(2013) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

(2013) Edward J. Gane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complicated relationships of amino acid substitution in hepatitis C virus core region andIL28Bgenotype influencing hepatocarcinogenesis

(2012) Norio Akuta et al.   HEPATOLOGY

Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients

(2012) Takashi Kumada et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

(2012) Eiichi Ogawa et al.   JOURNAL OF HEPATOLOGY

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

(2012) Anna S. Lok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

(2010) Yasuhiro Asahina et al.   HEPATOLOGY

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy

(2010) Chao-Hung Hung et al.   INTERNATIONAL JOURNAL OF CANCER

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

(2009) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

Standards of Medical Care in Diabetes--2010

(2009)   DIABETES CARE

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography

(2009) Ryota Masuzaki et al.   HEPATOLOGY

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

(2009) Norihiro Kokudo et al.   JOURNAL OF GASTROENTEROLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS